NCT02545439View on ClinicalTrials.gov

A Drug-drug Interaction Study of ALKS 5461 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions

Healthy Volunteers

Interventions

DRUG

ALKS 5461

Sublingual tablet given alone and in conjunction with Rifampin

Trial Locations (1)

66212

Alkermes Investigational Site, Overland Park

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alkermes, Inc.

INDUSTRY